Literature DB >> 27581413

New anti-tuberculosis drugs for special populations: a difficult-to-address issue.

Giovanni Sotgiu1, Emanuele Pontali2, Rosella Centis3, Lia D'Ambrosio4, Giovanni Battista Migliori3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27581413     DOI： 10.1183/13993003.01289-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

Review 1.  Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

Authors:  Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Marina Tadolini; Margareth Dalcolmo; Adrian Rendon; Susanna Esposito; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 2.  Bedaquiline: Fallible Hope Against Drug Resistant Tuberculosis.

Authors:  Priya Singh; Rashmi Kumari; Rup Lal
Journal:  Indian J Microbiol       Date:  2017-10-24       Impact factor: 2.461

Review 3.  Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Battista Migliori; Emanuele Pontali; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Marina Tadolini; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.